Mordechai Pras

892 total citations
10 papers, 668 citations indexed

About

Mordechai Pras is a scholar working on Molecular Biology, Rheumatology and Immunology. According to data from OpenAlex, Mordechai Pras has authored 10 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Rheumatology and 3 papers in Immunology. Recurrent topics in Mordechai Pras's work include Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers), Inflammasome and immune disorders (5 papers) and interferon and immune responses (2 papers). Mordechai Pras is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers), Inflammasome and immune disorders (5 papers) and interferon and immune responses (2 papers). Mordechai Pras collaborates with scholars based in Israel, United States and Italy. Mordechai Pras's co-authors include Pnina Langevitz, Deborah Zemer, Avi Livneh, Shai Padeh, Yelizaveta Torosyan, Joshua Shemer, A Migdal, E Sohar, Yael Shinar and Jae Jin Chae and has published in prestigious journals such as The American Journal of Human Genetics, Clinica Chimica Acta and Seminars in Arthritis and Rheumatism.

In The Last Decade

Mordechai Pras

10 papers receiving 644 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mordechai Pras Israel 9 632 337 186 113 100 10 668
Banu Balcı‐Peynircioğlu Türkiye 16 469 0.7× 306 0.9× 68 0.4× 74 0.7× 68 0.7× 37 606
B. Balci Türkiye 6 462 0.7× 265 0.8× 134 0.7× 113 1.0× 49 0.5× 8 490
M Dervichian France 7 457 0.7× 275 0.8× 155 0.8× 94 0.8× 30 0.3× 13 503
Özgül Soysal Türkiye 5 345 0.5× 173 0.5× 106 0.6× 79 0.7× 89 0.9× 8 400
Christian Vasseur France 4 459 0.7× 268 0.8× 84 0.5× 54 0.5× 61 0.6× 6 553
Emmanuelle Cochet France 7 607 1.0× 414 1.2× 98 0.5× 75 0.7× 97 1.0× 12 671
E. Rabinovich Israel 6 264 0.4× 138 0.4× 52 0.3× 63 0.6× 66 0.7× 13 313
E.J. Bodar Netherlands 6 335 0.5× 183 0.5× 110 0.6× 53 0.5× 99 1.0× 9 429
Oskar Schnappauf United States 7 291 0.5× 182 0.5× 47 0.3× 60 0.5× 39 0.4× 9 381
Tami Shohat Israel 9 245 0.4× 145 0.4× 51 0.3× 95 0.8× 34 0.3× 15 334

Countries citing papers authored by Mordechai Pras

Since Specialization
Citations

This map shows the geographic impact of Mordechai Pras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mordechai Pras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mordechai Pras more than expected).

Fields of papers citing papers by Mordechai Pras

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mordechai Pras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mordechai Pras. The network helps show where Mordechai Pras may publish in the future.

Co-authorship network of co-authors of Mordechai Pras

This figure shows the co-authorship network connecting the top 25 collaborators of Mordechai Pras. A scholar is included among the top collaborators of Mordechai Pras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mordechai Pras. Mordechai Pras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Shtrasburg, Shmuel, Mordechai Pras, Rivka Gal, Moshe Salai, & Avi Livneh. (2001). Inhibition of the second phase of amyloidogenesis in a mouse model by a single-dose colchicine regimen. Journal of Laboratory and Clinical Medicine. 138(2). 107–111. 16 indexed citations
2.
Torosyan, Yelizaveta, Yael Shinar, Elon Pras, et al.. (2001). A single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Behçet's disease (FMF-BD). European Journal of Human Genetics. 9(3). 191–196. 62 indexed citations
3.
4.
Torosyan, Yelizaveta, Jonathan Samuels, Michael Centola, et al.. (1999). Mutation and Haplotype Studies of Familial Mediterranean Fever Reveal New Ancestral Relationships and Evidence for a High Carrier Frequency with Reduced Penetrance in the Ashkenazi Jewish Population. The American Journal of Human Genetics. 64(4). 949–962. 219 indexed citations
5.
Shtrasburg, Shmuel, et al.. (1999). Pregnancy and amyloidogenesis: I. Offspring of amyloidotic mice are not predisposed to develop amyloidosis. Journal of Laboratory and Clinical Medicine. 134(2). 168–172. 8 indexed citations
6.
Langevitz, Pnina, Avi Livneh, Deborah Zemer, Joshua Shemer, & Mordechai Pras. (1997). Seronegative spondyloarthropathy in familial Mediterranean fever. Seminars in Arthritis and Rheumatism. 27(2). 67–72. 98 indexed citations
7.
Yakar, Shoshana, et al.. (1997). Isolation and purification of two major serum amyloid A isotypes SAA1 and SAA2 from the acute phase plasma of mice. Journal of Chromatography B Biomedical Sciences and Applications. 704(1-2). 69–76. 11 indexed citations
8.
Langevitz, Pnina, Deborah Zemer, Shai Padeh, et al.. (1996). The changing face of Familial Mediterranean Fever. Seminars in Arthritis and Rheumatism. 26(3). 612–627. 140 indexed citations
9.
Yakar, Shoshana, Avi Livneh, Batia Kaplan, & Mordechai Pras. (1995). The molecular basis of reactive amyloidosis. Seminars in Arthritis and Rheumatism. 24(4). 255–261. 18 indexed citations
10.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Banu Balcı‐Peynircioğlu Breakdown of academic impact, for papers by B. Balci Breakdown of academic impact, for papers by M Dervichian Breakdown of academic impact, for papers by Özgül Soysal Breakdown of academic impact, for papers by Christian Vasseur Breakdown of academic impact, for papers by Emmanuelle Cochet Breakdown of academic impact, for papers by E. Rabinovich Breakdown of academic impact, for papers by E.J. Bodar Breakdown of academic impact, for papers by Oskar Schnappauf Breakdown of academic impact, for papers by Tami Shohat
Rankless by CCL
2026